The Company has not disclosed a reason for the medication discontinuation, however in 2017, the FDA reported that olaparib capsules were being phased out of the US market. [UPDATE 9/6/18] Lynparza ...

Vazalore is indicated as a pain reliever, fever reducer, and for aspirin therapy indications. The Food and Drug Administration (FDA) has approved the supplemental New Drug Applications (sNDAs) for ...

Twenty-four healthy subjects (12 male and 12 female) were included in the trial. They were aged between 22 and 45 (mean 34.4) years, and had body mass indexes of 19.0-28.8 (mean 24.7) kg/m 2. Major ...

A phase I study of ombrabulin (O) combined with bevacizumab (B) in patients with advanced solid tumors (NCT01193595). A phase I study of R04929097, an oral gamma secretase inhibitor, in combination ...

Please provide your email address to receive an email when new articles are posted on . The FDA has given final approval to Perrigo Co.’s miniature 20 mg delayed-release omeprazole magnesium capsules ...

LYON, France--(BUSINESS WIRE)--MaaT Pharma announced today that it treated its first patient in a Phase 1 clinical trial to evaluate the safety and tolerability of MaaT033, a capsule formulation of ...

An important element of many manufacturing processes in the pharmaceutical industry is the blending of a small amount of Active Pharmaceutical Ingredient (API) with a bulk excipient, and then ...

A phase II study of patupilone in patients with metastatic hormone refractory prostate cancer (HRPC) who have progressed after docetaxel ...

Multiple factors affect oral delivery of therapeutic peptides such as acidic and enzymatic degradation in the upper gastrointestinal tract and poor intestinal Permeability. Get the essential updates ...